Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
29 oct. 2024 12h43 HE
|
Tevogen Bio Inc
CD8 Technology Services, LLC (“CD8 Technology”) to provide turn-key facility for Tevogen BioReinforces Tevogen Bio’s commitment to preserving shareholder valueExpected to further enhance Tevogen Bio’s...
Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc.
22 août 2024 16h35 HE
|
Vision Sensing Acquisition Corp.
Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc. Agrees to Terminate Previous Agreement with Mediforum Co., Ltd.
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
31 juil. 2024 09h45 HE
|
BioSig Technologies, Inc.
Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Bocana Resources Corp. – Provides an Update on the Proposed Bolivian Acquisition
24 juil. 2024 17h01 HE
|
Bocana Resources Corp.
CALGARY, Alberta, July 24, 2024 (GLOBE NEWSWIRE) -- Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) ("Bocana" or the "Company") announces it terminated the non-binding letter of intent dated...
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
17 juil. 2024 07h07 HE
|
SciSparc Ltd
SciSparc will receive additional payments and execution fees if certain milestones are met TEL AVIV, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
08 juil. 2024 08h30 HE
|
SciSparc Ltd
According to the agreement, SciSparc’s pharmaceuticals assets are valued at approximately $11.6 million TEL AVIV, Israel, July 08, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC)...
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
22 mai 2024 08h30 HE
|
Optimi Health Corp.
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany
21 mai 2024 08h56 HE
|
Xylo Technologies Ltd.
TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announces...
Bocana Resources Corp. Kori Kollo Review – Bolivia
17 avr. 2024 15h58 HE
|
Bocana Resources Corp.
CALGARY, Alberta, April 17, 2024 (GLOBE NEWSWIRE) -- Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) ("Bocana" or the "Company") – is pleased to provide additional information with respect to...
Power Leaves Corp. Enters Into LOI for RTO; Targets Public Listing in H1 2024
27 mars 2024 07h45 HE
|
Power Leaves Corp.
Upon Completion of a Successful Listing, PLC Would Become the First Publicly Traded Decocainized-coca Derivative Manufacturer & Distributor TORONTO, Ontario, March 27, 2024 (GLOBE NEWSWIRE)...